{"id":"https://openalex.org/W4404933797","doi":"https://doi.org/10.1158/1055-9965.27938579","title":"Supplementary Table S2 from Identification of High-Incidence Populations in the United States for Anti\u2013Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma","display_name":"Supplementary Table S2 from Identification of High-Incidence Populations in the United States for Anti\u2013Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma","publication_year":2024,"publication_date":"2024-12-02","ids":{"openalex":"https://openalex.org/W4404933797","doi":"https://doi.org/10.1158/1055-9965.27938579"},"language":"en","primary_location":{"id":"doi:10.1158/1055-9965.27938579","doi":"https://doi.org/10.1158/1055-9965.27938579","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1055-9965.27938579","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Identification_of_High-Incidence_Populations_in_the_United_States_for_Anti_Epstein-Barr_Virus_Serologic_Screening_for_Nasopharyngeal_Carcinoma/27938579/1/files/50907026.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Identification_of_High-Incidence_Populations_in_the_United_States_for_Anti_Epstein-Barr_Virus_Serologic_Screening_for_Nasopharyngeal_Carcinoma/27938579/1/files/50907026.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114239564","display_name":"Payton E. Clark","orcid":"https://orcid.org/0009-0003-9709-2131","observed_orcids":["https://orcid.org/0009-0003-9709-2131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Payton E. Clark","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-9709-2131","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008027539","display_name":"Kekoa Taparra","orcid":"https://orcid.org/0000-0001-8493-3868","observed_orcids":["https://orcid.org/0000-0001-8493-3868"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kekoa Taparra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8493-3868","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5015678568","display_name":"Jacob A. Miller","orcid":"https://orcid.org/0000-0002-8480-5492","observed_orcids":["https://orcid.org/0000-0002-8480-5492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacob A. Miller","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8480-5492","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.37450000643730164,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.37450000643730164,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.35109999775886536,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.14139999449253082,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.843999981880188},{"id":"https://openalex.org/keywords/nasopharyngeal-carcinoma","display_name":"nasopharyngeal carcinoma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/serological-screening","display_name":"serological screening","score":0.9190000295639038},{"id":"https://openalex.org/keywords/transition-probabilities","display_name":"transition probabilities","score":0.8799999952316284},{"id":"https://openalex.org/keywords/health-utility","display_name":"health utility","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cost-analysis","display_name":"cost analysis","score":0.5249999761581421},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C2778997737","wikidata":"https://www.wikidata.org/wiki/Q1693598","display_name":"Nasopharyngeal carcinoma","level":3,"score":0.9051703214645386},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.7582554817199707},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6213623285293579},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5911860466003418},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.5450329184532166},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.49591025710105896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4136888086795807},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22167402505874634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20438098907470703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19948643445968628},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.14819398522377014},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0966637134552002},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.06889665126800537},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.053539156913757324},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1055-9965.27938579","doi":"https://doi.org/10.1158/1055-9965.27938579","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1055-9965.27938579","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Identification_of_High-Incidence_Populations_in_the_United_States_for_Anti_Epstein-Barr_Virus_Serologic_Screening_for_Nasopharyngeal_Carcinoma/27938579/1/files/50907026.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/27938579","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Identification_of_High-Incidence_Populations_in_the_United_States_for_Anti_Epstein-Barr_Virus_Serologic_Screening_for_Nasopharyngeal_Carcinoma/27938579","pdf_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Identification_of_High-Incidence_Populations_in_the_United_States_for_Anti_Epstein-Barr_Virus_Serologic_Screening_for_Nasopharyngeal_Carcinoma/27938579","source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1055-9965.27938579","doi":"https://doi.org/10.1158/1055-9965.27938579","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1055-9965.27938579","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Identification_of_High-Incidence_Populations_in_the_United_States_for_Anti_Epstein-Barr_Virus_Serologic_Screening_for_Nasopharyngeal_Carcinoma/27938579/1/files/50907026.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404933797.pdf","grobid_xml":"https://content.openalex.org/works/W4404933797.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404933447","https://openalex.org/W4403097653","https://openalex.org/W4402906355","https://openalex.org/W3115019000","https://openalex.org/W2896968262","https://openalex.org/W7160235530","https://openalex.org/W7171292857","https://openalex.org/W2741129234","https://openalex.org/W4362480788","https://openalex.org/W2043037851"],"abstract_inverted_index":{"Table":[0],"S2.":[1],"Modeled":[2],"Transition":[3],"Probabilities,":[4],"Management":[5],"Assumptions,":[6],"Health":[7],"Utilities,":[8],"and":[9,16],"Costs":[10],"with":[11],"Parameter":[12],"Ranges":[13],"for":[14],"Deterministic":[15],"Probabilistic":[17],"Sensitivity":[18],"Analyses":[19]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2024-12-03T00:00:00"}